Sina Arham

Founder @ Fridays Health
GLP-1 | TRT | Peptides | Biomarkers | Longevity
US News & World Report Top 10 Telehealth

[Sina Arham @sinaarham]

@petersellis I feel personally attacked but I’m into it

[Sina Arham @sinaarham]

Two decades in the health industry taught me why personalized supplements fail: hand-mixing kills margins and scale.

I’m backing a SoCal team automating custom supplements at industrial scale.

The next $1B brand? Personalized and scalable.

DM me if you want to meet the founders.

[Sina Arham @sinaarham]

@lolhefe Thanks again, Jeff. Excellent work by you gents. Good company, great convos.

[Sina Arham @sinaarham]

@maxmarchione This is Abud coded @AbudBakri

[Sina Arham @sinaarham]

One of my favorite parts of the last year: the number of really good e-commerce operators now in my DMs building in telehealth.

They ask really smart questions that force me to take a closer look at my own decisions.

I’ve been in healthcare for nearly twenty years and my best advice to those of you building is that there’s no growth hack for trust:

Retention here is just care, measured over time.

[Sina Arham @sinaarham]

U.S. News & World Report just named Fridays Health one of the top GLP-1 telehealth companies, named alongside companies that originally inspired me to build in the space three years ago.

This distinction belongs to our clinicians, dietitians, counselors, trainers, and support staff.

‘Thank you’ falls short of capturing the gratitude that I have for the work you all do tirelessly.

I don’t always comment in the Slack channels but I do be lurkin’ and I see you all debate and advocate for ways to improve the program for our patients.

[Sina Arham @sinaarham]

U.S. News & World Report just named Fridays Health one of the top GLP-1 telehealth companies, named alongside companies that originally inspired me to build in the space three years ago.

This distinction belongs to our clinicians, dietitians, counselors, trainers, and support staff.

‘Thank you’ falls short of capturing the gratitude that I have for the work you all do tirelessly.

I don’t always comment in the Slack channels but I do be lurkin’ and I see you all debate and advocate for ways to improve the program for our patients.

[🌲 @lolhefe]

Last night i threw a dinner with my friend Enes.

It was exclusively for 9 &10 fig founders

I realized that whales hated events because they were never learning at them, only teaching.

So I made one for them and cut out all the bullshit.

Can’t wait to do it again, going to run it back in Q4 with something way crazier.

and they will ALWAYS be free

Thank you all for joining!

@jordanmenard @Jason______A @KFC_KevinChen @AdamMDavies @enesyilmazer @sinaarham @DrCamRx @charlie__chang @yngwood @danfleyshman and many more that i don’t have the twitter handles of.

[Sina Arham @sinaarham]

@BrianNorgard Golden hour in Newport tonight.

[Sina Arham @sinaarham]

@ManOnThePen @Starbucks Use code DAVEOTP to get it down to $4 a day at Fridays Health

[Sina Arham @sinaarham]

@ZachShurtleff Every man has two lives, and the second starts when he realizes he has just one.

[Sina Arham @sinaarham]

@AbudBakri Working on it

[Sina Arham @sinaarham]

@jamesonhaslam I just saw him at fashion island a few hours ago causally strolling solo and I thought it was him but my brain didn’t compute that it was likely.

[Sina Arham @sinaarham]

@dominic54 @carterwhoosh @BeyondWhoosh @whooshwellness Strive doing compounded peptides already?

[Sina Arham @sinaarham]

@ZachShurtleff

[Sina Arham @sinaarham]

@StuartBlitz This needs more love

[Sina Arham @sinaarham]

@Keithdavis85 @DrCamRx No agencies - build marketing in house.

[Sina Arham @sinaarham]

@maxmarchione @rorynotsorry We offer this for GLP-1 but also plan to do so with peptides later this year.

[Sina Arham @sinaarham]

@drmarlonperalta Spot on

[Sina Arham @sinaarham]

@ManOnThePen Sounds like gainz to me

[Sina Arham @sinaarham]

The comparison to early batteries is especially on point: limitations today don’t define the ceiling tomorrow. The real opportunity is building rigorous, evidence-driven frameworks around peptides rather than rejecting them outright.

Question: If peptides sit between pharma and wellness, who should be responsible for setting the standards of evidence and safety in this in-between space?